m6A enzymes found to be central to the development of AML

Share this post

A new molecular pathway that is required for acute myeloid leukemia (AML) development has been identified by a team of researchers for the first time. This work could provide a rationale for targeting the RNA methylation program in myeloid leukemia.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply